Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
and partial to full agonist at β4 containing receptors and α7 receptors
6]naphthyridine 4(41H)-oxide
TMC353121 is a a respiratory syncytial virus (RSV) fusion inhibitor as a candidate to treat human respiratory syncytial virus infection
24-96 hours) inhibits long-term A549 cells proliferation
including cytochrome C and apoptotic-inducing factor
Selpercatinib ethyl diphenylborinate and partial to full agonistSelpercatinib (LOXO 292) is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 163, has an IC50 of 14. 0 nM, 24. 1 nM, and 530. 7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively. Antineoplastic activity. Product information CAS Number: 2152628 33 4 Molecular Weight: 525. 60 Formula: C29H31N7O3 Chemical Name: 6 (2 hydroxy 2 methylpropoxy) 4 (6 {6 [(6 methoxypyridin 3 yl)methyl] 3,6 diazabicyclo[3. 1. 1]heptan 3
US$ 1800.00
US$ 367.50
US$ 105.00
US$ 95.00
US$ 125.00